Conclusion The theoretical appeal of a mots c and retatrutide stack lies in the potential for complementary actions that address metabolic health from both a fundamental cellular level (MOTS-c) and a systemic, hormonal regulation perspective (retatrutide)
What's Included: In person consultation in Tucson, AZ The starting dose of Semaglutide (Ozempic / Wegovy) (0.25mg for the first 4 weeks) if patient qualifies $499 monthly after your 1st month* Prescription (if eligible) B12 or Lipo Mino injections WEEKLY CHECK-IN VISITS WITH YOUR PROVIDER WHICH INCLUDE MEDICATION ADMINISTRATION, NUTRITION AND EXERCISE GUIDANCE Individualized weight loss management plan for reaching your goals in fitness, weight, and health at any age with an emphasis on longevity and wellness
impurity profiling and stability testing not required in most states) State boards of pharmacy conduct inspections, frequency varies by state (annual to every 3 years) Geographic distribution: Compounded semaglutide is manufactured at hundreds of compounding pharmacies across the U.S
2,339 participants randomized to 4 mg, 9 mg, 12 mg, or placebo: Placebo: 3.9% weight loss 4 mg: 17.6% average weight loss (~37 lbs) 9 mg: 23.7% average weight loss (~54 lbs) 12 mg: 2528.3% average weight loss (~70 lbs) 45.3% of participants achieved 30% weight loss At 104 weeks, participants with severe obesity on 9 mg or 12 mg achieved up to 30% total body weight loss a threshold historically associated only with bariatric surgery
Weight loss can vary, depending on which GLP-1 drug you use and the dosage
